US$ 28.69
glutathione reducing agent - The Tripeptide Antioxidant & and immune function glutathione composed of cysteine glycine
Description
Reconstitution: Add 3.0 mL bacteriostatic water approximately ~33.3 mg/mL concentration

CagriSema: Regulatory Status Novo Nordisk filed a New Drug Application with the FDA for CagriSema in weight management in December 2025, based on the REDEFINE 1 and REDEFINE 2 pivotal data

These findings suggest that accelerated loss of GSH can occur under oxidative stress, in part, due to GPx-1-mediated reduction of peroxides

The phase 2 and phase 3 trials focused primarily on total body weight reduction
